Measurement delay associated with the Guardian® RT continuous glucose monitoring system

نویسندگان

  • C Wei
  • D J Lunn
  • C L Acerini
  • J M Allen
  • A M Larsen
  • M E Wilinska
  • D B Dunger
  • R Hovorka
چکیده

AIMS Using compartment modelling, we assessed the time delay between blood glucose and sensor glucose measured by the Guardian RT continuous glucose monitoring system in young subjects with Type 1 diabetes (T1D). METHODS Twelve children and adolescents with T1D treated by continuous subcutaneous insulin infusion (male/female 7/5; age 13.1 +/- 4.2 years; body mass index 21.9 +/- 4.3 kg/m(2); mean +/- sd) were studied over 19 h in a Clinical Research Facility. Guardian RT was calibrated every 6 h and sensor glucose measured every 5 min. Reference blood glucose was measured every 15 min using a YSI 2300 STAT Plus Analyser. A population compartment model of sensor glucose-blood glucose kinetics was adopted to estimate the time delay, the calibration scale and the calibration shift. RESULTS The population median of the time delay was 15.8 (interquartile range 15.2, 16.5) min, which was corroborated by correlation analysis between blood glucose and 15-min delayed sensor glucose. The delay has a relatively low intersubject variability, with 95% of individuals predicted to have delays between 10.4 and 24.3 min. Population medians (interquartile range) for the scale and shift are 0.800 (0.777, 0.823) (unitless) and 1.66 (1.47, 1.84) mmol/l, respectively. CONCLUSIONS In young subjects with T1D, the total time delay associated with the Guardian RT system was approximately 15 min. This is twice that expected on physiological grounds, suggesting a 5- to 10-min delay because of data processing. Delays above 25 min are rarely to be observed.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Accuracy and Reliability of Continuous Glucose Monitoring in the Intensive Care Unit: A Head-to-Head Comparison of Two Subcutaneous Glucose Sensors in Cardiac Surgery Patients

Hyperglycemia, hypoglycemia, and glucose variability are common during intensive care unit (ICU) stay and are associated with increased mortality (1–3). Continuous glucose monitoring (CGM) is a promising tool to assist glucose control, but the accuracy and reliability of these devices in critically ill patients is uncertain (4,5). Therefore, we studied two different CGM devices postoperatively ...

متن کامل

Delays in minimally invasive continuous glucose monitoring devices: a review of current technology.

Through the use of enzymatic sensors-inserted subcutaneously in the abdomen or ex vivo by means of microdialysis fluid extraction-real-time minimally invasive continuous glucose monitoring (CGM) devices estimate blood glucose by measuring a patient's interstitial fluid (ISF) glucose concentration. Signals acquired from the interstitial space are subsequently calibrated with capillary blood gluc...

متن کامل

Validation and feasibility of two Continuous Glucose Monitoring

Purpose: To validate two Continuous Glucose Monitoring systems (CGMs) against arterial AccuChek® point-of-care glucose measurements in critically ill patients. Methods: Two CGMs, Guardian RT® (GRT) and Freestyle Navigator® (FsN), were used for 5 days in mechanically ventilated patients with Multiple Organ Dysfunction syndrome. The measurements at T=0, T +10 min and T + 20 min were linked to T=0...

متن کامل

Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes

BACKGROUND Women with gestational diabetes mellitus (GDM) are required to control their blood glucose shortly after GDM diagnosis to minimize adverse pregnancy outcomes. A real time-continuous glucose monitoring system (RT-CGMS) provides the patient with continuous information about the alterations in levels of the blood glucose. This visibility may empower the patient to modify her lifestyle a...

متن کامل

Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.

I ntensive self-management with frequent self-monitoring of blood glucose (SMBG) is important in type 1 diabetes to achieve good metabolic control (1–3). Nevertheless, many patients still experience episodes of unrecognized hypoand hyperglycemia (4). Novel technologies for continuous glucose monitoring (CGM) that provide information about glucose excursions are now available. Previous studies r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 27  شماره 

صفحات  -

تاریخ انتشار 2010